In addition, understanding how chemotherapeutic drugs signal to p53-independent pathways and cell cycle checkpoints remains of central relevance to cancer treatment, and using yeast to help dissect these pathways should help in targeted drug design. The gene discussed is TP53; the disease is cancer.